Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom
Crossref DOI link: https://doi.org/10.1007/s13300-016-0219-2
Published Online: 2017-01-05
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hunt, Barnaby
Ye, Qing
Valentine, William J.
Ashley, Donna
Funding for this research was provided by:
Novo Nordisk
Text and Data Mining valid from 2017-01-05
Article History
Received: 28 October 2016
First Online: 5 January 2017